"Het Dijklander Ziekenhuis wil een ziekenhuis zijn waar u zich welkom voelt. Een ziekenhuis waar het niet alleen draait om de vraag ‘wat is er met u’ maar ook om ‘wat is voor u belangrijk?’ Wij willen onze patiënten écht begrijpen. We zijn geworteld in de regio’s Waterland en West-Friesland en bieden zorg aan al hun inwoners. Als opleidingsziekenhuis delen we kennis en ervaring. Het houdt ons scherp en zo blijven we ons ontwikkelen. Samenwerking met andere partijen zoals (academische) ziekenhuizen, huisartsen en thuiszorg vinden wij voor goede zorg onmisbaar."

During the past decade, Westfriesgasthuis conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westfriesgasthuis" #1 sponsor was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "Dijklander Ziekenhuis" with 2 trials sponsored, "The Netherlands Cancer Institute" with 2 trials sponsored and "Agendia" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westfriesgasthuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 4 trials as a collaborator, "Agendia" with 1 trials as a collaborator, "Amphia Hospital" with 1 trials as a collaborator, "Amsterdam UMC, location VUmc" with 1 trials as a collaborator and "Arbeitsgemeinschaft fur Internistische Onkologie" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Westfriesgasthuis" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Acute Coronary Event" (1 trials), "Arterial Disease" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Westfriesgasthuis" in a lesser frequency.

Most popular intervention types in "Westfriesgasthuis" are "Drug" (7 trials), "Procedure" (4 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "CHOP regimen" (1 trials), "Chemotherapy" (1 trials), "Consultation by telephone" (1 trials), "Elastic compression therapy with a standard duration of 24 months" (1 trials) and "FEC-T+Pertuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Westfriesgasthuis" are 14 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Westfriesgasthuis". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Westfriesgasthuis, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Westfriesgasthuis, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".